AnalystBook Research · Company Intelligence

MeiraGTx Holdings plc

MGTXNasdaq

Built from MeiraGTx Holdings plc's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Revenue increased 144.6% to $81.4M, while Net income increased 22.7% to ($114.2M).

The read at a glance✓ Audited against SEC data
  • ScaleFY2025 revenue $81.4MWatch
  • ProfitabilityNet income ($114.2M)Watch
  • Cash generationFree cash flow ($50.2M)Note
  • AccountingFormula distress score · no manipulation flag · earnings quality greyWatch
  • Insiders0 buys; 5 sells in 365 daysNote
  • CapitalComparable payout data unavailableNote

Business

MeiraGTx Holdings plc: There is no guarantee that we will receive in a timely fashion or at all the additional milestone payments contemplated under the Asset Purchase Agreement or the revenues associated with our manufacture of the commercial supply of the RPGR Product under the Supply Agreement.

Where the revenue comes from

Fiscal 2025, as MeiraGTx Holdings plc reports it. History and quarterly detail are in the app.

  • License revenue$75.0M
  • Service revenue - related party$6.4M

Latest filings

  • 10-Q · Quarterly report2026-08-13
  • 8-K · Company announcement2026-08-13
  • 8-K · Company announcement2026-07-07
  • 8-K · Company announcement2026-06-15
  • 10-Q · Quarterly report2026-05-14
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about MeiraGTx Holdings plc, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.